Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan van den Broek

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Frontiers in Microbiology|January 10, 2017
Hijacking Complement Regulatory Proteins for Bacterial Immune EvasionElise S Hovingh, Bryan van den Broek, Ilse Jongerius
Plos Pathogens|July 26, 2017
Acquisition of C1 inhibitor by Bordetella pertussis virulence associated gene 8 results in C2 and C4 consumption away from the bacterial surfaceElise S Hovingh, Bryan van den Broek, Betsy Kuipers, et al.
Journal of Innate Immunity|July 4, 2019
Common Genetic Variants in the Complement System and their Potential Link with Disease Susceptibility and Outcome of Invasive Bacterial InfectionBryan van den Broek, Michiel van der Flier, Ronald de Groot, et al.
Blood Advances|August 9, 2020
Eculizumab impairs Neisseria meningitidis serogroup B killing in whole blood despite 4CMenB vaccination of PNH patientsJeroen D Langereis, Bryan van den Broek, Sjoerd Franssen, et al.
The Pediatric Infectious Disease Journal|July 21, 2021
Neisseria meningitidis Serogroup Z Meningitis in a Child With Complement C8 Deficiency and Potential Cross Protection of the MenB-4C VaccineBryan van den Broek, Jordy P M Coolen, Marien I de Jonge, et al.
Rheumatology (Oxford, England)|March 4, 2025
Belimumab concentrations and immunogenicity in relation to drug effectiveness and safety in SLE within a Swedish real-world settingAlvaro Gomez, Tomas Walhelm, Floris C Loeff, et al.
Kidney International|May 21, 2022
Eculizumab impairs killing of Neisseria meningitidis serogroup B in atypical hemolytic uremic syndrome patients vaccinated with MenB-4CBryan van den Broek, Michiel van der Flier, Nicole C A J van de Kar, et al.
The Pediatric Infectious Disease Journal|May 18, 2023
A Novel Combination of Host Protein Biomarkers to Distinguish Bacterial From Viral Infections in Febrile Children in Emergency CareChantal D Tan, Bryan van den Broek, Rebecca S Womersley, et al.
Infection and Immunity|January 31, 2018
Streptococcus pneumoniae PspC Subgroup Prevalence in Invasive Disease and Differences in Contribution to Complement EvasionErika van der Maten, Bryan van den Broek, Marien I de Jonge, et al.
Journal of Immunological Methods|July 3, 2024
Belimumab concentration measurements using a homologous anti-idiotype immunoassayFloris C Loeff, Ioannis Parodis, Tomas Walhelm, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Microbiology|January 10, 2017
Hijacking Complement Regulatory Proteins for Bacterial Immune EvasionElise S Hovingh, Bryan van den Broek, Ilse Jongerius
Plos Pathogens|July 26, 2017
Acquisition of C1 inhibitor by Bordetella pertussis virulence associated gene 8 results in C2 and C4 consumption away from the bacterial surfaceElise S Hovingh, Bryan van den Broek, Betsy Kuipers, et al.
Journal of Innate Immunity|July 4, 2019
Common Genetic Variants in the Complement System and their Potential Link with Disease Susceptibility and Outcome of Invasive Bacterial InfectionBryan van den Broek, Michiel van der Flier, Ronald de Groot, et al.
Blood Advances|August 9, 2020
Eculizumab impairs Neisseria meningitidis serogroup B killing in whole blood despite 4CMenB vaccination of PNH patientsJeroen D Langereis, Bryan van den Broek, Sjoerd Franssen, et al.
The Pediatric Infectious Disease Journal|July 21, 2021
Neisseria meningitidis Serogroup Z Meningitis in a Child With Complement C8 Deficiency and Potential Cross Protection of the MenB-4C VaccineBryan van den Broek, Jordy P M Coolen, Marien I de Jonge, et al.
Rheumatology (Oxford, England)|March 4, 2025
Belimumab concentrations and immunogenicity in relation to drug effectiveness and safety in SLE within a Swedish real-world settingAlvaro Gomez, Tomas Walhelm, Floris C Loeff, et al.
Kidney International|May 21, 2022
Eculizumab impairs killing of Neisseria meningitidis serogroup B in atypical hemolytic uremic syndrome patients vaccinated with MenB-4CBryan van den Broek, Michiel van der Flier, Nicole C A J van de Kar, et al.
The Pediatric Infectious Disease Journal|May 18, 2023
A Novel Combination of Host Protein Biomarkers to Distinguish Bacterial From Viral Infections in Febrile Children in Emergency CareChantal D Tan, Bryan van den Broek, Rebecca S Womersley, et al.
Infection and Immunity|January 31, 2018
Streptococcus pneumoniae PspC Subgroup Prevalence in Invasive Disease and Differences in Contribution to Complement EvasionErika van der Maten, Bryan van den Broek, Marien I de Jonge, et al.
Journal of Immunological Methods|July 3, 2024
Belimumab concentration measurements using a homologous anti-idiotype immunoassayFloris C Loeff, Ioannis Parodis, Tomas Walhelm, et al.
Pageof 1